A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

<b>Background:</b> Germline mutations in the Chek2 kinase gene (<i>CHEK2</i>) have been associated with a range of cancer types. Recently, a large deletion of exons 9 and 10 of <i>CHEK2</i> was identified in several unrelated patients with breast cancer of Czech o...

Бүрэн тодорхойлолт

-д хадгалсан:

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Cezary Cybulski, Dominika Wokołorczyk, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bohdan Górski, Tadeusz Dębniak, Bartłomiej Masojć, Anna Jakubowska, Bartłomiej Gliniewicz, A. Sikorski, Małgorzata Stawicka, Dariusz Godlewski, Zbigniew Kwias, Andrzej Antczak, K Krajka, Wojciech Lauer, Marek Sosnowski, Paulina Sikorska‐Radek, Krzysztof Bar, Robert Klijer, Romuald Zdrojowy, Bartosz Małkiewicz, Wen‐Chien Ko, Tomasz Borkowski, Marek Szwiec, Steven A. Narod, Jan Lubiński
Формат:	Artigo
Хэл сонгох:	англи
Хэвлэсэн:	2006
Онлайн хандалт:	https://doi.org/10.1136/jmg.2006.044974 https://jmg.bmj.com/content/jmedgenet/43/11/863.full.pdf
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Ижил төстэй зүйлс

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer
-н: Cybulski, C, зэрэг
Хэвлэсэн: (2006)

The risk of breast cancer in women with a CHEK2 mutation
-н: Cybulski, Cezary, зэрэг
Хэвлэсэн: (2012)

CHEK2 mutations as markers for high risk of breast cancer
-н: Cybulski, Cezary, зэрэг
Хэвлэсэн: (2012)

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor
-н: Ogrodniczak, Alicja, зэрэг
Хэвлэсэн: (2022)

The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations
-н: Tomiczek-Szwiec, Joanna, зэрэг
Хэвлэсэн: (2022)

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer
-н: Łukomska, Alicja, зэрэг
Хэвлэсэн: (2021)

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?
-н: Cezary Cybulski, зэрэг
Хэвлэсэн: (2006)

CHEK2 Is a Multiorgan Cancer Susceptibility Gene
-н: Cezary Cybulski, зэрэг
Хэвлэсэн: (2004)

Population Screening of CHEK2 Mutations in Poland
-н: Cybulski, Cezary, зэрэг
Хэвлэсэн: (2006)

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband
-н: Gronwald, J, зэрэг
Хэвлэсэн: (2009)

An inherited NBN mutation is associated with poor prognosis prostate cancer
-н: Cezary Cybulski, зэрэг
Хэвлэсэн: (2012)

Pathologic Complete Response Rates in Young Women With <i>BRCA1</i>-Positive Breast Cancers After Neoadjuvant Chemotherapy
-н: Tomasz Byrski, зэрэг
Хэвлэсэн: (2009)

Genetic predisposition to male breast cancer in Poland
-н: Szwiec, Marek, зэрэг
Хэвлэсэн: (2021)

PALB2 mutations and prostate cancer risk and survival
-н: Wokołorczyk, Dominika, зэрэг
Хэвлэсэн: (2021)

Mutations in <scp> <i>ATM</i> </scp> , <scp> <i>NBN</i> </scp> and <scp> <i>BRCA2</i> </scp> predispose to aggressive prostate cancer in Poland
-н: Dominika Wokołorczyk, зэрэг
Хэвлэсэн: (2020)

CHEK2 Is a Multiorgan Cancer Susceptibility Gene
-н: Cybulski, C., зэрэг
Хэвлэсэн: (2004)

Inherited Variants in BLM and the Risk and Clinical Characteristics of Breast Cancer
-н: Kluźniak, Wojciech, зэрэг
Хэвлэсэн: (2019)

BRCA1 and BRCA2 Mutations in Polish Women with Ductal Carcinoma In Situ
-н: Sylwia Feszak, зэрэг
Хэвлэсэн: (2025)

Coverage of the Genetic Background of Breast Cancer in the Polish Population
-н: Serrano-Fernández, Pablo, зэрэг
Хэвлэсэн: (2006)

BARD1 is a Low/Moderate Breast Cancer Risk Gene: Evidence Based on an Association Study of the Central European p.Q564X Recurrent Mutation
-н: Suszynska, Malwina, зэрэг
Хэвлэсэн: (2019)

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles
-н: Cybulski, C, зэрэг
Хэвлэсэн: (2013)

An inherited NBN mutation is associated with poor prognosis prostate cancer
-н: Cybulski, C, зэрэг
Хэвлэсэн: (2013)

The spectrum of mutations predisposing to familial breast cancer in Poland
-н: Cezary Cybulski, зэрэг
Хэвлэсэн: (2019)

Inherited NBN Mutations and Prostate Cancer Risk and Survival
-н: Rusak, Bogna, зэрэг
Хэвлэсэн: (2019)

The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs
-н: Lubiński, Jan, зэрэг
Хэвлэсэн: (2005)

<b> <i>NBS1</i> </b> Is a Prostate Cancer Susceptibility Gene
-н: Cezary Cybulski, зэрэг
Хэвлэсэн: (2004)

Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian Cancer
-н: Bartłomiej Górski, зэрэг
Хэвлэсэн: (2000)

Population Screening for Cancer Family Syndromes in the West Pomeranian Region of Poland
-н: Gronwald, Jacek, зэрэг
Хэвлэсэн: (2006)

Antioxidant Properties of Zinc and Copper—Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers
-н: Milena Matuszczak, зэрэг
Хэвлэсэн: (2024)

Folic acid and cancer risk in BRCA1 carriers
-н: Durda, Katarzyna, зэрэг
Хэвлэсэн: (2012)

Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families
-н: Dębniak, Tadeusz, зэрэг
Хэвлэсэн: (2015)

Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?
-н: Stempa, Klaudia, зэрэг
Хэвлэсэн: (2021)

Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility
-н: Trubicka, Joanna, зэрэг
Хэвлэсэн: (2010)

Serum Selenium Level and 10-Year Survival after Melanoma
-н: Rogoża-Janiszewska, Emilia, зэрэг
Хэвлэсэн: (2021)

Inherited variants in XRCC2 and the risk of breast cancer
-н: Kluźniak, Wojciech, зэрэг
Хэвлэсэн: (2019)

A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet
-н: Huzarski, Tomasz, зэрэг
Хэвлэсэн: (2006)

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
-н: Tomasz Byrski, зэрэг
Хэвлэсэн: (2008)

Serum Selenium Level Predicts 10-Year Survival after Breast Cancer
-н: Szwiec, Marek, зэрэг
Хэвлэсэн: (2021)

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?
-н: Byrski, T, зэрэг
Хэвлэсэн: (2012)

Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers
-н: Adam Kiljańczyk, зэрэг
Хэвлэсэн: (2024)